Literature DB >> 9129843

Acute coronary syndromes.

D D Yun1, J S Alpert.   

Abstract

Acute coronary syndromes are defined as unstable angina, non-Q-wave myocardial infarction, and Q-wave myocardial infarction. These entities remain among the commonest life-threatening illnesses in industrialized nations. Prompt recognition of a patient with an acute coronary syndrome is important since appropriate therapy can markedly improve the patient's prognosis. Reperfusion strategies for patients with Q-wave myocardial infarction, and anticoagulation and antiplatelet therapy for patients with unstable angina or non-Q-wave myocardial infarction are examples of such potentially life-saving interventions. A number of adjunctive pharmacological interventions are also beneficial following reperfusion therapy in patients with Q-wave myocardial infarction. Management of Complications following Q-wave myocardial infarction has improved markedly in recent years. This is particularly the case with postinfarction ischemia or heart failure. Persistent arrhythmias, and in particular ventricular arrhythmias, remain a troubling challenge for the clinician. Reperfusion therapy markedly reduces the incidence of complications following Q-wave myocardial infarction.

Entities:  

Mesh:

Year:  1997        PMID: 9129843     DOI: 10.1159/000177335

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  9 in total

Review 1.  Future directions in thrombolysis.

Authors:  J T Willerson; P Zoldhelyi
Journal:  Clin Cardiol       Date:  1999-08       Impact factor: 2.882

Review 2.  Sibrafiban.

Authors:  M Dooley; K L Goa
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

Review 3.  Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention.

Authors:  K L Goa; S Noble
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

Review 4.  Emerging biomarkers for the detection of cardiovascular diseases.

Authors:  Sreenu Thupakula; Shiva Shankar Reddy Nimmala; Haritha Ravula; Sudhakar Chekuri; Raju Padiya
Journal:  Egypt Heart J       Date:  2022-10-20

Review 5.  Tirofiban. A review of its use in acute coronary syndromes.

Authors:  K J McClellan; K L Goa
Journal:  Drugs       Date:  1998-12       Impact factor: 9.546

Review 6.  Platelets miRNA as a Prediction Marker of Thrombotic Episodes.

Authors:  Michal Bijak; Malgorzata Dzieciol; Joanna Rywaniak; Joanna Saluk; Marzenna Zielinska
Journal:  Dis Markers       Date:  2016-11-30       Impact factor: 3.434

Review 7.  Biomarkers in acute myocardial infarction: current perspectives.

Authors:  Suleyman Aydin; Kader Ugur; Suna Aydin; İbrahim Sahin; Meltem Yardim
Journal:  Vasc Health Risk Manag       Date:  2019-01-17

8.  Correlations between Kidney and Heart Function Bioindicators and the Expressions of Toll-Like, ACE2, and NRP-1 Receptors in COVID-19.

Authors:  Rabab Hussain Sultan; Basem H Elesawy; Tarek M Ali; Maged Abdallah; Hebatallah Hany Assal; Amr E Ahmed; Osama M Ahmed
Journal:  Vaccines (Basel)       Date:  2022-07-11

9.  Direct quantification of cell-free, circulating DNA from unpurified plasma.

Authors:  Sarah Breitbach; Suzan Tug; Susanne Helmig; Daniela Zahn; Thomas Kubiak; Matthias Michal; Tommaso Gori; Tobias Ehlert; Thomas Beiter; Perikles Simon
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.